Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10550081
Crystalline freebase forms of a biphenyl compound
granted -
US 10550084
Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same
granted -
US 10550129
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
granted -
US 10548954
Factor IX polypeptides and methods of use thereof
granted -
US 10548962
Use of the salmonella SPP type III secretion proteins as a protective vaccination
granted -
US 10548916
Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock
granted -
US 10548946
Therapeutic compositions for neutralizing type I interferons, and methods of use
granted -
US 10548953
Factor VIII-XTEN fusions and uses thereof
granted -
US 10548905
Amorphous onapristone compositions and methods of making the same
granted -
US 10548899
Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity
granted -
US 10548948
Methods of treating fungal infections
granted -
US 10548877
Aromatic ring compound
granted -
US 10548889
Compositions of CXCR4 inhibitors and methods of preparation and use
granted -
US 10548875
Glycopyrrolate salts
granted -
US 10548850
Therapeutic composition comprising insulin prepared for delivery into an intestinal tract
granted -
US 10548863
Process to prepare treprostinil, the active ingredient in Remodulin®
granted -
US 10548856
Compounds and methods for modulating serotonin receptors in the periphery
granted -
US 2020030465
Stable, concentrated radionuclide complex solutions
granted -
US 2020030466
Stable, concentrated radionuclide complex solutions
granted -
US 10544126
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
granted -
US 10543268
Genetically engineered swine influenza virus and uses thereof
granted -
US 10543221
Beta-lactamase inhibitors, formulations, and uses thereof
granted -
US 10544188
Inhibitor of apoptosis protein (IAP) antagonists
granted -
US 10544108
Hydrazide containing nuclear transport modulators and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.